Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
MOLECULAR-GENETICS OF HEREDITARY ELLIPTOCYTOSIS AND HEREDITARY SPHEROCYTOSIS
Autore:
DELAUNAY J; ALLOISIO N; MORLE L; BAKLOUTI F; DALLAVENEZIA N; MAILLET P; WILMOTTE R;
Indirizzi:
INST PASTEUR,CNRS URA 1171,LAB GENET MOL HUMAINE LYON FRANCE CTR HOSP BICETRE,INSERM U299 LE KREMLIN BICETR FRANCE HEMATOL LAB LE KREMLIN BICETR FRANCE
Titolo Testata:
Annales de genetique
fascicolo: 4, volume: 39, anno: 1996,
pagine: 209 - 221
SICI:
0003-3995(1996)39:4<209:MOHEAH>2.0.ZU;2-0
Fonte:
ISI
Lingua:
ENG
Soggetto:
BETA-SPECTRIN GENE; DELETIONAL FRAMESHIFT MUTATION; ALPHA-I DOMAIN; SPLICE SITE MUTATION; HETERODIMER CONTACT SITE; DIMER SELF-ASSOCIATION; RED-CELL MEMBRANE; CODON CHANGE ARG; HEMOLYTIC-ANEMIA; PROTEIN-4.2 GENE;
Keywords:
HEREDITARY ELLIPTOCYTOSIS; HEREDITARY SPHEROCYTOSIS; MOLECULAR BASIS;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
93
Recensione:
Indirizzi per estratti:
Citazione:
J. Delaunay et al., "MOLECULAR-GENETICS OF HEREDITARY ELLIPTOCYTOSIS AND HEREDITARY SPHEROCYTOSIS", Annales de genetique, 39(4), 1996, pp. 209-221

Abstract

Red cells owe their mechanical properties, that is, their resistance and their elastic deformability, to a protein network that laminates the lipid bilayer and to proteins spanning the latter. All proteins areinterconnected. Their structure, as well as the structure of the corresponding genes, will be outlined. Numerous mutations have allowed to reclassify hereditary elliptocytosis (HE) and poikilocytosis (HP), and, more recently, hereditary spherocytosis (HS) into well defined subsets of hereditary hemolytic anemias. HE stems from changes in the SPTA1, SPTB, EL1 and (exceptionally) GPYC genes that encode spectrin alpha-and beta-chains, protein 4.1 and glycophorin C/D, respectively. HS derives from alterations in the ANK1, EPB3 and ELB42 genes, encoding ankyrin, band 3 and protein 4.2, respectively, and also in the SPTA1 and SPTB genes. We will present a repertory of the known mutations. Innumerable polymorphisms will not be considered here, except for a few remarkable ones. Some general points must be stressed on. (a) Clinically conspicuous disorders are often the result of two alleles interacting in trans to one another. Whereas one allele causes moderate symptoms byitself, the other one is usually silent in the simple heterozygous (and exceptionally in the homozygous) state. As a result, the number of potentially pathogenic alleles is much more important than had been initially suspected. (b) The reduction or the loss of a protein within multiprotein assemblies are frequently encountered in red cell membranegenetic diseases; it leads to the disruption of the complexes with the possible disappearance of other proteins than the mutated protein. (c) The above genes being also expressed in nonerythroid tissues, one starts finding multisyndromic conditions adding non-hematological manifestations to hemolysis. It is puzzling, though, that such situations are not more frequent. (d) In practice, the molecular diagnosis of HE and HS has reached a semi-routine stage that helps very much the paediatricians and haematologists.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/11/20 alle ore 08:28:37